
Balchem (BCPC) Stock Forecast & Price Target
Balchem (BCPC) Analyst Ratings
Bulls say
Balchem is expected to experience continued growth in their Human Nutrition and Health segment, along with a strong balance sheet and low leverage ratio. Risks to their outlook include slower growth in their base businesses, inflationary pressures, and potential disruptions to their European business. However, the company's expansion into new nutrition products and potential partnerships could mitigate these risks. Financial metrics, such as net interest expense and cash flows, remain strong and the company's stock may be undervalued based on a comparable universe-derived forward P/E multiple of 36.8x. Revenue and earnings for fourth quarter 2025 and full-year 2025 were in line with expectations, and forecasts for full-year 2026 and 2027 suggest continued growth and improvements in margins. The recent imposition of anti-dumping duties in Europe for one of Balchem's key products is expected to positively impact sales in that region. The company's effective tax rate is anticipated to increase slightly in the coming years, but Balchem's strong financial position and potential for M&A activity suggest potential for future share repurchases or debt repayment.
Bears say
Balchem is projected to have steady top-line growth and fairly consistent earnings over the next few years, but the recent modest revenue miss and potential impact from geopolitical tensions may hinder its performance. Additionally, while the HNH segment remains strong, there have also been some misses in the animal health and nutrition and specialty product segments. The company's gross margin has also seen a slight decrease due to higher manufacturing input costs. Overall, the company may face challenges in the near future that could affect its bottom line.
This aggregate rating is based on analysts' research of Balchem and is not a guaranteed prediction by Public.com or investment advice.
Balchem (BCPC) Analyst Forecast & Price Prediction
Start investing in Balchem (BCPC)
Order type
Buy in
Order amount
Est. shares
0 shares